Literature DB >> 35800456

Variants in PRKCE and KLC1, Potential Regulators of Type I Psoriasis.

Jianxiao Xing1, Ying Wang1, Xincheng Zhao1, Junqin Li1, Ruixia Hou1, Xuping Niu1, Guohua Yin1, Xinhua Li1, Kaiming Zhang2.   

Abstract

Purpose: Psoriasis is a multifactorial disease with a complex genetic predisposition. The pathophysiology of psoriasis is associated with genetic variants. To better characterize gene variants in psoriasis and identify the relationship between clinical characteristics and variant genes in its pathogenesis. Patients and
Methods: DNA was extracted and purified from eight pairs of monozygotic twins with psoriasis discordance and 282 type I psoriasis patients. Thirteen variable genes were amplified and sequenced using the Sanger method after whole genome sequencing.
Results: Thirteen genes were found to be variable in eight pairs of monozygotic twins with psoriasis discordance. Among the 13 genes, the variant frequencies of protein kinase C epsilon (PRKCE) (c.240T>C, 35.9% vs 47.7%, P < 0.05) and kinesin light chain 1 (KLC1) (c.216A>G, 2.9% vs 98.1%, P< 0.01) were significantly lower in psoriasis than in normal Asian individuals. Additionally, we found considerable differences in the relationship between variants in genes CADM2, JPH2, SPTLC3 and clinical characteristics stratified by medical history and family history. Moreover, the variants in MEGF6 (39.52% vs 22.50%, χ 2=3.83, p < 0.05) showed a stronger association with the mild group (PASI ≤10) than the heavy group.
Conclusion: Our results provide a comprehensive correlation analysis of regulatory genes that are regulated in psoriasis. This integrated analysis offers novel insight into the pathogenic mechanisms involved in psoriasis.
© 2022 Xing et al.

Entities:  

Keywords:  KLC1; PRKCE; gene variants; psoriasis

Year:  2022        PMID: 35800456      PMCID: PMC9255717          DOI: 10.2147/CCID.S371719

Source DB:  PubMed          Journal:  Clin Cosmet Investig Dermatol        ISSN: 1178-7015


  45 in total

1.  Constitutive presence of a catalytic fragment of protein kinase C epsilon in a small cell lung carcinoma cell line.

Authors:  G Baxter; E Oto; S Daniel-Issakani; B Strulovici
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

2.  Genome-wide association study of psoriasis in an Egyptian population.

Authors:  Yosra Bejaoui; Mareike Witte; Mohamed Abdelhady; Mohammad Eldarouti; Nermeen M A Abdallah; Ashraf Antar Elghzaly; Ziyad Tawhid; Mohammad Ali Gaballah; Hauke Busch; Matthias Munz; Mareike Wendorff; Eva Ellinghaus; Andre Franke; Saleh M Ibrahim
Journal:  Exp Dermatol       Date:  2019-05       Impact factor: 3.960

3.  Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patients.

Authors:  Yunjian Pan; Chongze Yuan; Chao Cheng; Yiliang Zhang; Yuan Ma; Difan Zheng; Shanbo Zheng; Yuan Li; Yan Jin; Yihua Sun; Haiquan Chen
Journal:  Int J Cancer       Date:  2018-11-04       Impact factor: 7.396

4.  Psoriasis pharmacogenetics: HLA-Cw*0602 as a marker of therapeutic response to ustekinumab.

Authors:  Inês Raposo; Cláudia Carvalho; Andreia Bettencourt; Berta Martins Da Silva; Luiz Leite; Manuela Selores; Tiago Torres
Journal:  Eur J Dermatol       Date:  2017-10-01       Impact factor: 3.328

Review 5.  The role of PI3K/AKT/FOXO signaling in psoriasis.

Authors:  Miao Zhang; Xiaoyan Zhang
Journal:  Arch Dermatol Res       Date:  2018-11-27       Impact factor: 3.017

6.  Familial aggregation of psoriatic arthritis.

Authors:  V Chandran; C T Schentag; J E Brockbank; F J Pellett; S Shanmugarajah; S M A Toloza; P Rahman; D D Gladman
Journal:  Ann Rheum Dis       Date:  2008-06-04       Impact factor: 19.103

Review 7.  The current landscape of psoriasis genetics in 2020.

Authors:  Kotaro Ogawa; Yukinori Okada
Journal:  J Dermatol Sci       Date:  2020-05-28       Impact factor: 4.563

8.  A genome-wide perspective of genetic variation in human metabolism.

Authors:  Thomas Illig; Christian Gieger; Guangju Zhai; Werner Römisch-Margl; Rui Wang-Sattler; Cornelia Prehn; Elisabeth Altmaier; Gabi Kastenmüller; Bernet S Kato; Hans-Werner Mewes; Thomas Meitinger; Martin Hrabé de Angelis; Florian Kronenberg; Nicole Soranzo; H-Erich Wichmann; Tim D Spector; Jerzy Adamski; Karsten Suhre
Journal:  Nat Genet       Date:  2009-12-27       Impact factor: 38.330

9.  Characterisation of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1.

Authors:  U Hüffmeier; J Lascorz; T Becker; F Schürmeier-Horst; A Magener; A B Ekici; S Endele; C T Thiel; S Thoma-Uszynski; R Mössner; K Reich; W Kurrat; T F Wienker; H Traupe; A Reis
Journal:  J Med Genet       Date:  2009-06-11       Impact factor: 6.318

Review 10.  Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes.

Authors:  Valerio Caputo; Claudia Strafella; Andrea Termine; Annunziata Dattola; Sara Mazzilli; Caterina Lanna; Terenzio Cosio; Elena Campione; Giuseppe Novelli; Emiliano Giardina; Raffaella Cascella
Journal:  J Cell Mol Med       Date:  2020-10-31       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.